Bovine Respiratory Disease Complex (BRD / Shipping fever)

Bovine Respiratory Disease Complex (BRD), commonly known as shipping fever, represents the most economically significant disease affecting the North American cattle industry and one of the most important health challenges in cattle production worldwide. This multifactorial syndrome involves the interaction of various viral and bacterial pathogens with host factors and environmental stressors to produce respiratory illness ranging from mild upper respiratory infection to severe, life-threatening pneumonia. The complexity of BRD stems from the multiple agents involved and the essential role of predisposing factors in disease development.

BRD affects cattle across all production segments but causes its greatest impact in feedlot operations and among recently weaned, commingled, or transported cattle. The disease accounts for the largest proportion of morbidity and mortality in North American feedlots, with some estimates suggesting BRD affects fifteen to forty-five percent of feedlot cattle and causes over half of all feedlot deaths. The syndrome also significantly impacts cow-calf operations, dairy facilities, and stocker operations, though the presentation and primary pathogens may differ between production systems.

The economic impact of BRD extends far beyond treatment costs and death losses. Affected cattle experience reduced feed efficiency, decreased weight gain, and prolonged time to market weight. Carcass quality is often compromised, with increased condemnations and reduced grades. Treatment costs, labor for sick animal care, and the expense of prevention programs including vaccination and metaphylaxis add to the financial burden. Conservative estimates place annual BRD losses in the United States alone at over one billion dollars, making it the single most costly disease affecting beef production.

Management of BRD requires a comprehensive approach addressing prevention, early detection, and appropriate treatment. While no intervention can completely eliminate BRD given its multifactorial nature, strategic programs combining vaccination, stress reduction, appropriate nutrition, and prompt treatment of affected animals can substantially reduce both incidence and severity. Understanding the interactions between pathogens, host immunity, and environmental factors enables producers and veterinarians to develop targeted programs appropriate for their specific operations and risk situations.

The primary causes of BRD involve a complex interaction between viral agents, bacterial pathogens, host factors, and environmental stressors. Viral infections typically initiate the disease process by damaging the respiratory tract's defense mechanisms and predisposing to secondary bacterial infection. Key viral agents include infectious bovine rhinotracheitis virus (IBR/BHV-1), bovine viral diarrhea virus (BVDV), parainfluenza-3 virus (PI3), and bovine respiratory syncytial virus (BRSV). These viruses damage the respiratory epithelium, impair mucociliary clearance, and suppress immune function, creating conditions favorable for bacterial invasion.

Bacterial pathogens complete the disease process, causing the severe pneumonia characteristic of clinical BRD. Mannheimia haemolytica (formerly Pasteurella haemolytica) represents the most important bacterial agent, responsible for the majority of severe BRD cases and deaths. Pasteurella multocida contributes to many cases, particularly in younger cattle. Histophilus somni (formerly Haemophilus somnus) causes respiratory disease and may produce systemic illness affecting multiple organ systems. Mycoplasma bovis has emerged as an increasingly recognized pathogen, often associated with chronic, treatment-resistant cases and joint infections.

Environmental and management factors play essential roles in BRD development, often determining whether exposure to pathogens results in clinical disease. Transportation stress, the origin of the term shipping fever, suppresses immune function and increases susceptibility. Commingling of cattle from multiple sources exposes animals to unfamiliar pathogens while adding social stress. Weather extremes, particularly cold, wet conditions or rapid weather changes, stress cattle and may impair respiratory defenses. Poor ventilation, overcrowding, and dusty conditions increase pathogen exposure and irritate respiratory tissues.

Risk factors for BRD include characteristics of both the individual animal and the management situation. Recently weaned calves face elevated risk due to the stress of separation from dams combined with immune systems still developing from maternal antibody loss. Cattle subjected to long transportation distances experience more stress and disease than those moved short distances or not at all. Lightweight cattle, those under five hundred pounds, show higher BRD rates than heavier animals. Previous lack of vaccination or immune priming leaves cattle vulnerable when exposed to pathogens. Bulls often experience higher BRD rates than steers or heifers, possibly due to behavioral factors and stress responses.

The pathophysiology of BRD involves sequential compromise of respiratory defenses followed by overwhelming bacterial infection. Viral infection damages the epithelial lining of the upper and lower respiratory tract, destroying the ciliated cells responsible for mucociliary clearance of pathogens and debris. Viral infection also impairs alveolar macrophages, the primary cellular defense against bacteria in the lower respiratory tract. With these defenses compromised, bacterial pathogens that normally inhabit the upper respiratory tract as commensals can colonize the lower airways and lung tissue. The resulting bacterial pneumonia triggers intense inflammatory responses that, while attempting to eliminate the infection, often cause substantial tissue damage. In severe cases, the combination of infection and inflammatory response produces consolidation of lung tissue, respiratory failure, and death.

Early warning signs of BRD are often subtle and require careful observation to detect. Affected cattle may show decreased feed intake as one of the first indicators, eating less enthusiastically or approaching the feed bunk later than herdmates. Mild depression, characterized by a slightly drooped head or reduced alertness, may be apparent to experienced observers. Early respiratory signs include occasional coughing and slightly increased respiratory rate, though these changes can be easy to miss in group housing situations. Cattle in early BRD stages may lag behind the group when moved or show subtle reluctance to walk normally.

Common symptoms of established BRD are more readily apparent and form the basis for clinical identification in feedlot and other production settings. Elevated body temperature, typically ranging from 104°F to 107°F (40°C to 41.7°C), represents a hallmark finding in acute cases. Nasal discharge progresses from clear and watery in early stages to thick, mucopurulent material as infection advances. Increased respiratory rate and effort become obvious, with affected cattle breathing faster and more laboredly than healthy penmates. Coughing, both spontaneous and elicited by handling or movement, is frequently observed. Decreased feed intake progresses to complete anorexia in severe cases.

Behavioral changes in cattle with BRD reflect both the systemic illness and respiratory compromise experienced by affected animals. Depression becomes increasingly pronounced, with cattle appearing dull, unresponsive, and disinterested in their surroundings. Affected animals often separate from the group, standing alone in corners of pens or pastures. Activity decreases markedly, with sick cattle reluctant to move even when encouraged. Cattle may stand with head extended and elbows abducted to ease breathing. Reduced rumination reflects both decreased feed intake and the energy demands of fighting infection.

Physical examination findings in BRD cases reveal the extent of respiratory system involvement. Auscultation of the lungs often detects abnormal sounds including increased bronchial tones, crackles, and wheezes over affected lung areas. Consolidated or abscessed lung regions may produce areas of absent breath sounds. Increased respiratory rate and effort are visually apparent and quantifiable on examination. Mucous membrane color may appear congested or cyanotic in severe cases. Dehydration develops rapidly in cattle that stop drinking, evidenced by sunken eyes, decreased skin turgor, and tacky mucous membranes.

Symptom progression in untreated BRD typically follows a predictable course over several days. The prodromal period of mild, nonspecific signs typically lasts one to two days before more obvious respiratory symptoms develop. Over the following two to four days, respiratory signs progress from mild to severe, with increasing temperature, respiratory effort, and depression. Without treatment, severely affected cattle may die within five to seven days of symptom onset. However, timely treatment during the early stages typically produces marked improvement within twenty-four to forty-eight hours, emphasizing the importance of early detection.

Emergency symptoms requiring immediate intervention include extreme respiratory distress characterized by open-mouth breathing, severely extended head and neck, and foaming at the mouth. Body temperature exceeding 107°F (41.7°C) indicates severe, potentially life-threatening infection. Cattle that are unable or unwilling to rise require urgent attention. Signs of septicemia including cold extremities, rapid weak pulse, and profound depression indicate systemic spread of infection. Cyanotic (blue-tinged) mucous membranes signal severe oxygen deprivation requiring immediate action. Any of these findings should trigger emergency veterinary intervention as they indicate immediately life-threatening disease.

Clinical examination forms the foundation of BRD diagnosis in most production settings. Visual assessment of cattle for depression, respiratory effort, nasal discharge, and separation from the group identifies animals requiring closer evaluation. Temperature measurement confirms fever, with readings above 104°F (40°C) supporting BRD diagnosis in animals showing appropriate clinical signs. Thoracic auscultation reveals abnormal lung sounds in areas of pneumonia. The combination of fever, depression, respiratory signs, and characteristic lung sounds provides sufficient basis for presumptive diagnosis and treatment initiation in most field situations.

Diagnostic testing helps confirm BRD diagnosis, identify specific pathogens, and guide treatment selection in individual cases or outbreak investigations. Deep nasopharyngeal swabs or transtracheal wash samples can be cultured to identify bacterial pathogens and determine antimicrobial sensitivity patterns. Viral detection through PCR testing or antigen detection identifies specific viral agents involved. Blood samples support complete blood count evaluation showing inflammatory changes and serum chemistry assessment of metabolic status. In valuable animals or diagnostic dilemmas, thoracic ultrasonography provides non-invasive assessment of lung consolidation and pleural involvement.

Differential diagnosis must consider other causes of respiratory disease and fever in cattle. Atypical interstitial pneumonia produces severe respiratory distress but follows different epidemiology and responds poorly to antimicrobials. Acute bovine pulmonary edema and emphysema, often triggered by pasture changes, presents with sudden severe respiratory distress. Foreign body pneumonia from aspiration must be considered in appropriate contexts. Mycoplasma bovis pneumonia may present similarly but often follows a more chronic course and responds poorly to standard BRD treatment. Infectious causes of fever without primary respiratory involvement, including blackleg, malignant edema, and septicemia from other sources, require differentiation.

Herd-level diagnostics become important in operations experiencing excessive BRD rates or poor treatment response. Necropsy examination of fatal cases provides definitive information about disease pathology and can guide pathogen identification through culture and other testing of fresh tissues. Vaccination history review helps identify gaps in protection or suggests need for program modification. Analysis of arrival weights, source demographics, transportation circumstances, and environmental conditions at disease onset helps identify risk factors amenable to management intervention. Antimicrobial sensitivity testing of isolates from multiple cases helps characterize resistance patterns affecting treatment decisions.

Emergency treatment for severe BRD cases focuses on immediate respiratory support and intensive antimicrobial therapy. Cattle in severe respiratory distress may benefit from oxygen supplementation if available. Rapid-acting antimicrobials with good lung tissue penetration should be administered immediately upon identifying critically ill animals. High-dose corticosteroid administration may help reduce life-threatening inflammation in selected severe cases, though use remains somewhat controversial due to potential immunosuppressive effects. Fluid therapy addresses dehydration that rapidly develops in anorectic, febrile cattle. Emergency cases require close monitoring and may need multiple treatment interventions over a compressed timeframe.

Medical management of standard BRD cases centers on antimicrobial therapy targeting the bacterial pathogens responsible for pneumonia. Multiple antimicrobial classes demonstrate efficacy against BRD pathogens, including macrolides such as tulathromycin and tilmicosin, fluoroquinolones like enrofloxacin and danofloxacin, cephalosporins including ceftiofur, and florfenicol. Selection among these options considers factors including spectrum of activity, duration of action, withdrawal time requirements, cost, and previous treatment history suggesting resistance patterns. Single long-acting injections offer convenience and ensure complete dosing, while shorter-acting drugs may require multiple treatments.

Anti-inflammatory therapy complements antimicrobial treatment by reducing the inflammatory response contributing to clinical signs and tissue damage. Non-steroidal anti-inflammatory drugs such as flunixin meglumine, meloxicam, and ketoprofen reduce fever, decrease inflammation, and improve animal comfort and appetite. These medications also help protect against the lung tissue damage caused by excessive inflammatory response to infection. Anti-inflammatory treatment should be administered concurrently with antimicrobials for maximum benefit in acute cases.

Supportive care enhances treatment outcomes and speeds recovery in BRD cases. Providing easy access to fresh water encourages rehydration of febrile, dehydrated cattle. Offering palatable, high-quality feed supports energy needs and helps maintain rumen function during illness. Environmental management to provide shade in hot weather, windbreaks in cold weather, and dry bedding improves animal comfort. Separating sick animals from healthy penmates reduces competition for resources and enables closer monitoring. Minimizing handling and stress during the treatment period allows animals to focus energy on fighting infection.

Herd treatment protocols establish consistent approaches for BRD management across operations. Written protocols should define criteria for identifying sick animals, specify first-line treatment regimens, establish timelines for expected response, and outline criteria for treatment changes or culling. Protocols should address record-keeping requirements, drug withdrawal management, and employee training needs. Regular review of treatment outcomes enables protocol refinement based on actual performance. Consultation with the herd veterinarian ensures protocols reflect current best practices and regulatory requirements.

Treatment decisions must balance individual animal needs with economic realities of production settings. Early treatment of animals showing initial signs provides the best opportunity for full recovery with minimal intervention. Treatment costs, including drug expense, labor, and potentially extended feeding periods, must be weighed against the animal's value and likelihood of recovery. Chronic, non-responsive cases that have failed multiple treatment attempts often require culling decisions. Animals meeting humane slaughter criteria may be shipped following appropriate withdrawal periods, while those not fit for transport may require euthanasia. Veterinary guidance helps producers make appropriate decisions for individual situations.

Recovery timeline for BRD varies considerably based on disease severity and promptness of treatment initiation. Cattle treated early in the disease course, within the first twenty-four to forty-eight hours of clinical signs, typically show marked improvement within one to two days and may return to essentially normal function within a week. More advanced cases require longer recovery periods, often one to three weeks, and may have residual lung damage affecting long-term performance. Chronic cases that fail to respond to treatment or experience relapse may never fully recover and often require management decisions regarding salvage slaughter or euthanasia.

Post-treatment care and monitoring ensure complete recovery and identify animals requiring additional intervention. Treated cattle should be observed at least twice daily for the first several days following treatment, watching for continued improvement in attitude, appetite, and respiratory status. Temperature monitoring can help track resolution of infection, with persistent or recurrent fever suggesting inadequate treatment response. Cattle not showing clear improvement within three to four days of initial treatment typically require re-evaluation and possible treatment change. Complete return of appetite and normal activity levels indicates successful recovery.

Prognosis factors influencing recovery include the severity of initial illness, timing of treatment relative to disease onset, and degree of lung damage sustained. Cattle treated early before extensive pneumonia develops have excellent prognosis, with most returning to normal health and performance. Animals with severe, advanced pneumonia have more guarded prognosis, and some experience permanent lung damage affecting future performance. Cattle that relapse after initial treatment improvement face poorer outcomes than those responding to first treatment. Co-morbidities including concurrent infections, previous illness, or underlying health problems negatively impact prognosis.

Return to production considerations recognize that recovered BRD cattle often perform differently than never-affected animals. Studies consistently show that cattle treated for BRD gain more slowly, require longer feeding periods, and produce lower-quality carcasses than healthy contemporaries. These performance penalties persist even in animals appearing clinically normal following recovery. For these reasons, some operations implement management practices such as marketing treated cattle separately or adjusting performance expectations. Drug withdrawal periods must be observed before slaughter to ensure meat safety, with specific withdrawal times varying by product used.

Vaccination protocols form a cornerstone of BRD prevention programs, though no vaccine program can eliminate the disease entirely. Modified live virus vaccines against IBR, BVDV, PI3, and BRSV stimulate immune responses against primary viral agents predisposing to bacterial pneumonia. Bacterial vaccines against Mannheimia haemolytica and Pasteurella multocida provide some protection against primary bacterial pathogens, though efficacy varies. Vaccination timing should allow immune response development before anticipated stress events, with most programs vaccinating calves at branding or weaning and providing boosters before shipping. For incoming cattle of unknown vaccination history, receiving vaccination should occur promptly upon arrival.

Biosecurity measures help limit pathogen exposure and reduce disease pressure in cattle operations. Sourcing cattle from fewer suppliers and avoiding sale barn purchases reduces exposure to diverse pathogen strains. Quarantine of new arrivals, when practical, allows identification of incubating disease before exposure to resident cattle. Isolation of sick animals prevents transmission to healthy penmates. Cleaning and disinfection of facilities between groups reduces environmental pathogen loads. Control of visitors and vehicles moving between operations limits mechanical transmission of pathogens.

Nutritional prevention addresses the role of adequate nutrition in maintaining immune competence and stress resistance. Cattle entering stressful situations such as weaning, shipping, or feedlot entry should be in good body condition with adequate nutritional reserves. Receiving diets should provide adequate energy and protein while encouraging feed consumption during the transition period. Trace mineral supplementation, particularly of copper, zinc, and selenium, supports immune function. Vitamin A and vitamin E supplementation may enhance immune response and tissue integrity. Water availability and quality deserve attention, as newly arrived cattle may be unfamiliar with water systems.

Management practices significantly influence BRD risk and should be optimized to reduce disease pressure. Preconditioning programs that wean calves well in advance of sale, provide vaccination, and adapt cattle to bunk feeding substantially reduce BRD rates compared to non-preconditioned cattle. Minimizing transportation distance and duration reduces shipping stress. Avoiding extreme weather conditions for cattle movements, when possible, reduces environmental stress. Reducing time from sale through transportation to arrival at final destination limits exposure to stressful conditions. Appropriate stocking density and adequate bunk space reduce competition stress.

Metaphylaxis, the treatment of all animals in a group at arrival or during high-risk periods, represents a prevention strategy used in many feedlot operations. Administration of long-acting antimicrobials to all arriving cattle provides protection during the highest-risk period for BRD development. This approach significantly reduces BRD morbidity and mortality in high-risk cattle populations. However, concerns about antimicrobial stewardship have led to increasing emphasis on targeted approaches, applying metaphylaxis only to cattle meeting specific high-risk criteria. The decision to use metaphylaxis should balance disease control benefits against antimicrobial use considerations.

Daily management and monitoring for BRD requires systematic observation of cattle for early disease signs. Cattle should be observed at least twice daily, with morning observation particularly valuable as sick animals are often more easily identified before feeding activity begins. Observers should be trained to recognize subtle signs including mild depression, slightly increased respiratory rate, decreased appetite, and separation from the group. Observation should occur from multiple vantage points and include watching cattle both at rest and during movement. Consistent, trained observation represents one of the most valuable tools for early BRD detection and successful treatment outcomes.

Environmental and facility management significantly impacts BRD risk and should be optimized for respiratory health. Ventilation in enclosed or semi-enclosed facilities must provide adequate fresh air exchange without creating drafts on cattle. Dust control through appropriate bedding management, pen surface maintenance, and water application during dry conditions reduces respiratory irritation. Drainage should prevent accumulation of standing water and mud that stresses cattle and promotes pathogen survival. Wind protection through natural or constructed barriers reduces cold stress during inclement weather. Shade structures prevent heat stress during warm weather.

Herd health programs addressing BRD should incorporate prevention, detection, and treatment components appropriate for the specific operation type and risk level. Vaccination schedules should be established and consistently implemented, with programs adapted to operation type and cattle population. Arrival processing protocols should be standardized, including appropriate vaccination, parasite control, and initial treatment decisions. Treatment protocols should be written, veterinarian-approved, and consistently followed. Regular veterinary consultation helps ensure programs reflect current best practices and address emerging challenges.

Record keeping and monitoring systems enable evaluation of BRD prevention and treatment program effectiveness. Individual animal records should document treatment dates, products used, withdrawal dates, and outcomes. Pen or group-level records track morbidity rates, treatment rates, and mortality. Analysis of these data over time identifies trends requiring attention. Comparison with industry benchmarks helps assess program performance relative to realistic expectations. Necropsy records from fatal cases provide valuable diagnostic information.

Economic considerations profoundly influence BRD management decisions at every level. Prevention investments including vaccination, preconditioning premiums, and management improvements should be evaluated against expected disease reduction benefits. Treatment costs must be balanced against realistic recovery expectations and animal value. Chronic non-responsive cases require difficult decisions balancing treatment costs against salvage value. The substantial economic impact of BRD makes investment in prevention programs generally advantageous, though specific cost-benefit calculations vary with cattle prices, disease pressure, and operational factors.

All cattle breeds are susceptible to BRD, with no breed demonstrating complete resistance to the disease complex. However, research has identified some differences in BRD susceptibility between breeds, suggesting genetic components to disease resistance. Bos indicus breeds and Bos indicus crosses generally show lower BRD rates than British or European breeds, possibly related to differences in stress response, immune function, or behavioral patterns. Among Bos taurus breeds, some studies suggest breed differences in BRD susceptibility, though findings are not entirely consistent across studies and environments.

Production type and management system profoundly influence BRD risk regardless of breed genetics. Feedlot cattle experience the highest BRD rates due to the combination of commingling, transportation stress, and intensive management. Stocker operations receiving lightweight calves from diverse sources face similar challenges. Cow-calf operations typically experience lower rates, though outbreaks can occur following stressful events such as weaning or severe weather. Dairy operations see BRD primarily in calves and young stock, with environmental factors in calf housing playing important roles. Within any production system, individual characteristics including age, weight, previous vaccination, and stress exposure influence individual animal risk.

Genetic selection and testing for BRD resistance represent emerging areas of research with potential future application. Studies have identified genetic markers associated with BRD susceptibility and resistance, suggesting selection for improved disease resistance may be possible. Expected progeny differences (EPDs) for health traits including BRD susceptibility are under development by some breed associations. However, practical application of genetic selection for BRD resistance remains limited, with current prevention programs relying primarily on management, vaccination, and environmental factors. As genomic tools advance, the ability to select for animals with improved innate resistance to BRD may become a valuable addition to comprehensive disease prevention programs.

Commonly co-occurring conditions with BRD reflect both predisposing factors and complications of the primary disease. Infectious bovine rhinotracheitis frequently accompanies or precedes BRD, with IBR virus infection damaging respiratory defenses and predisposing to bacterial pneumonia. Bovine viral diarrhea, particularly persistent infection, severely compromises immune function and increases BRD risk and severity. Parasite infections, especially during the stress of weaning and shipping, compound immune suppression and nutritional deficits. Liver abscesses, common in feedlot cattle, sometimes occur alongside BRD, both related to the stress and management of intensive feeding.

Conditions with similar symptoms to BRD require differentiation for appropriate treatment. Atypical interstitial pneumonia presents with acute severe respiratory distress but follows different epidemiology and pathophysiology, responding poorly to standard BRD treatment. Acute bovine pulmonary edema and emphysema, often triggered by pasture changes, causes severe respiratory compromise. Mycoplasma bovis infection may present similarly to other BRD pathogens but often follows a chronic, treatment-resistant course requiring specific management approaches. Non-respiratory causes of fever and depression including septicemia from other sources and clostridial diseases must be considered in differential diagnosis.

Complications and sequelae of BRD extend the disease's impact well beyond the acute illness period. Chronic pneumonia develops in some cattle despite treatment, resulting in persistent lung damage and compromised performance. Lung abscesses may form in areas of severe pneumonia, sometimes rupturing to cause pleuritis or spreading to other organs. Fibrinous pleuritis causes adhesions between lung and chest wall, permanently compromising respiratory function. Myocarditis, pericarditis, and arthritis may develop through hematogenous spread of infection. These complications contribute to the chronic non-responsive category of BRD cases requiring management decisions about continued treatment versus culling.